Institute of Cognitive Neuroscience, Huaibei Normal University, Huaibei 235000, China.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
Int J Environ Res Public Health. 2019 Dec 6;16(24):4970. doi: 10.3390/ijerph16244970.
The purpose of our study was to carry out a meta-analysis of current literature to determine whether total mastectomy and breast-conserving surgery induce different outcomes in quality of life, based on the breast-cancer-specific module of the European Organizaation for Research and Treatment of Cancer core questionnaire (EORTC QLQ-BR23) used postoperatively. A systematic literature search of PubMed and EMBASE was conducted. Observational clinical studies that compared the quality of life in different surgery groups and presented empirical findings were selected. Six studies met the inclusion criteria. Breast-conserving surgery has statistically significant better outcomes than mastectomy in three of the eight outcomes measured in the EORTC QLQ-BR23, namely body image (standard mean difference, SMD = 1.742, 95% CI 0.579-2.905, = 0.003), future perspective (SMD = 0.606, 95% CI 0.075-1.138, = 0.025) and systemic therapy side effects (SMD = -0.641, 95% CI 0.101-1.181, = 0.020). Our study highlighted that breast-conserving surgery was preferred over mastectomy because breast-conserving surgery leads to better outcomes in body image, future perspectives and less systemic side effects.
我们的研究目的是进行文献的荟萃分析,以确定全乳房切除术和保乳手术是否会在术后基于欧洲癌症研究与治疗组织核心问卷(EORTC QLQ-BR23)的乳腺癌特定模块导致生活质量的不同结果。我们对 PubMed 和 EMBASE 进行了系统的文献检索。选择了比较不同手术组生活质量并提供经验发现的观察性临床研究。符合纳入标准的有 6 项研究。保乳手术在 EORTC QLQ-BR23 测量的 8 个结果中的 3 个方面具有统计学意义上的更好结果,即身体形象(标准均数差,SMD=1.742,95%置信区间 0.579-2.905,=0.003)、未来展望(SMD=0.606,95%置信区间 0.075-1.138,=0.025)和全身治疗副作用(SMD=-0.641,95%置信区间 0.101-1.181,=0.020)。我们的研究强调,保乳手术优于乳房切除术,因为保乳手术可在身体形象、未来展望和较少的全身副作用方面带来更好的结果。